Aloglip 12.5
Form: Tablet
Strength: 12.5mg
Generic Name: Alogliptin
Company: Navana Pharmaceuticals Ltd.
MRP:৳ 12.0 (Strip=10)
Per Piece: ৳ 1.20
Is Antibiotic: No
Indications
Aloglip 12.5 is used along with diet and exercise to help control blood sugar levels in adults with type-2 diabetes mellitus.
Pharmacology
Aloglip 12.5 is a DPP-4 inhibitor that works by increasing the levels of hormones that help regulate blood sugar. These hormones, such as GLP-1 and GIP, are released from the small intestine after eating and help release insulin from the pancreas. These hormones also reduce sugar production in the liver. In type 2 diabetes, the body has lower levels of GLP-1, but the response to Aloglip 12.5 remains active.
Dosage & Administration
The usual dose is 25 mg once a day for patients with normal kidney function or mild kidney problems, or as directed by the doctor.
Interaction
Aloglip 12.5 is mainly removed by the kidneys. There are no major drug interactions observed with other drugs that affect the liver or kidneys.
Contraindications
Aloglip 12.5 should not be used by patients who have had serious allergic reactions to Alogliptin or similar products, such as anaphylaxis or severe skin reactions.
Side Effects
Common side effects include a sore throat, headache, and upper respiratory infections.
Pregnancy & Lactation
If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor before using this medicine. Aloglip 12.5 should only be used during pregnancy if absolutely necessary. Aloglip 12.5 is not known if Aloglip 12.5 passes into breast milk, so caution is advised while breastfeeding.
Precautions & Warnings
If you experience symptoms of pancreatitis, stop taking Aloglip 12.5 right away. Serious allergic reactions and liver problems have been reported, so if you notice unusual symptoms, seek medical advice. If used with other diabetes medications like insulin or sulfonylurea, a lower dose of those may be needed to prevent low blood sugar.
Overdose Effects
In case of overdose, Aloglip 12.5 is important to monitor the patient and provide supportive care. If needed, treatment may include removing the unabsorbed drug from the stomach. However, dialysis is unlikely to be helpful in removing the drug from the body.
Therapeutic Class
Aloglip 12.5 belongs to the Dipeptidyl Peptidase-4 (DPP-4) inhibitors class of medications.
Storage Conditions
Store below 30°C, away from light and moisture. Keep out of the reach of children.
Similar Brands of Alogliptin (Tablet – 12.5mg)
| Brand Name | Form | Strength | Company | MRP (৳) |
|---|---|---|---|---|
| Aglip 12.5 | Tablet | 12.5mg | Eskayef Pharmaceuticals Ltd. | 12.0 |